Pain Warriors Unite - (202) 792-5600

Pain Warriors Unite

Calling ALL Pain Warriors, It's NOW or NEVER!

Calling ALL Pain Warriors, It's NOW or NEVER!

Calling ALL Pain Warriors, It's NOW or NEVER!Calling ALL Pain Warriors, It's NOW or NEVER!
Pain Warriors Unite

Calling ALL Pain Warriors, It's NOW or NEVER!

Calling ALL Pain Warriors, It's NOW or NEVER!

Calling ALL Pain Warriors, It's NOW or NEVER!Calling ALL Pain Warriors, It's NOW or NEVER!Calling ALL Pain Warriors, It's NOW or NEVER!

Fellow Pain Warriors --

We must UNITE to fight for the future of pain management in America. 

Click Below get involved NOW!


Fellow Pain Warriors --

We must UNITE to fight for the future of pain management in America. 

Click Below get involved NOW!


Welcome to Our Community Website

Welcome to the Chronic Intractable Pain Community's first ALL INCLUSIVE website! 

This website was created BY pain patients FOR pain patients, advocates, health care professionals, and anyone else who would like to join in our collective cause to reveal the atrocities happening to MILLIONS of Patients and Physicians as a result of the government's MISGUIDED policies in their attempt to reduce overdose deaths. 

We must stand TOGETHER and fight back against the OVER REGULATION of prescription pain medications.  WE are  advocating for FAIR and EQUAL  policies that will protect our interests and preserve access to ALL modalities that pertain to the treatment of CHRONIC & ACUTE pain and to prevent the UNDER treatment, NON treatment, or ABANDONMENT of Americans in pain. 


Coronavirus COVID19 Information

Federal government response

The overall federal government response is at

This page offers the most updated health-related guidance and information on coronavirus.

VA resources

For the latest VA updates on coronavirus and commonsense tips on preventing its spread, visit

For the latest blogs about coronavirus, visit

Rumor control

FEMA has a rumor control page at

CDC information

The Centers for Disease Control, or CDC, offers information about protecting a person and what a person should do if sick, please visit

Food and drugs

The U.S. Food and Drug Administration offers the latest information on their site at

The administration is monitoring medical product and food supply chains for potential shortages and disruptions. 

The U.S. Department of Agriculture also has information about food safety and pet safety at

Social security and Medicare information

Americans receiving social security can stay up-to-date with the latest at

Medicare offers their latest updates at

The page covers information about lab tests, medical hospitalizations and a Medicare Advantage Plan.


People can find out what’s going on in their STATE at



Coronavirus unemployment benefits. Here's who qualifies and how much they get. - NBC News

Pandemic Unemployment Assistance, which covers people who are unable to work because of the coronavirus outbreak

Coronavirus Stimulus Package FAQ: Checks, Unemployment and More

 The $2 trillion relief bill will send money directly to Americans, greatly expand unemployment coverage and make a number of other changes

Out of work due to coronavirus shutdowns? How to file for unemployment benefits - NBC News
The record-shattering spike in unemployment filings this week means a surge in Americans seeking assistance. But what are the most important steps to take?

Coronavirus Resources | U.S. Department of Labor
Under the guidance, federal law permits significant flexibility for states to amend their laws to provide unemployment insurance benefits in multiple scenarios related to COVID-19

Coronavirus resources |
Many people are experiencing unexpected difficulties during the outbreak of the coronavirus (COVID-19). is here to help. 

Avoid Scams

The Federal Trade Commission, or FTC, has a page helping people avoid coronavirus SCAMS at

Unfortunately, some people are taking advantage of fears surrounding coronavirus. 

The Consumer Financial Protection Bureau also has information about protecting finances at

The site educates people on consumer complaints, protecting credit, dealing with debt and more.


**ALERT** Meet with Your State & Federal Representatives

schedule a meeting Today!

It's CRUCIAL for all CPP'S to  Schedule a meeting or attend local events to urge your representatives to implement  our National Pain Policy.

The only way to change the current pathway which has created a hostile regulatory environment is to GET INVOLVED IN THE LEGISLATIVE PROCESS ASAP 



Send them the link to the HHS Pain Task Force's Report here: 


You can find upcoming  events  in your State  HERE 

Legislative Outreach Kit

Our Legislative Outreach Kit Contains Instructions,  Tips, and Links to locate & Contact Your State and Federal Representatives & Regulatory Agencies.  Click the button below to download the kit. 



HHS Warns Doctors To Not Swing Too Far On Pendulum Away From Opioids For Chronic Pain Patients

As the country grapples with the opioid epidemic, there's been a broad crackdown on opioids in general. Now, HHS is urging doctors not to go too far in cutting off prescriptions. Other news on the crisis focuses on the court challenges to Purdue Pharma and other drugmakers.


HHS' assistant secretary for health Dr. Brett Giroir urged clinicians to collaborate with patients on deciding how fast they reduce or stop their opioid therapies.

"We know that it is critical that clinicians manage acute and chronic pain in an individualized, patient-centered way," Giroir said.

There have been numerous reports of individuals being abruptly cut off their medication regimen after the Centers for Disease Control and Prevention's Guideline for Prescribing Opioids for Chronic Pain in 2016, according to Giroir.

The CDC guidelines recommended clinicians prescribe opioids only after exhausting other pain therapies, prescribe the lowest effective dosage, evaluate patients within 1 to 4 weeks of starting opioid therapy for chronic pain, and taper or discontinue opioids if the harms OUTWEIGH the benefits.

"Clearly, we believe that there has been a misinterpretation of the [CDC] guidelines, which were very clear," Giroir said. "People have inappropriately misinterpreted cautionary dosage thresholds as mandates for dose reduction."


Urgent Press Release from CDC


Pain Management Task Force Meeting overview

RE: Overview of Pain Management Task Force Meeting & Recommendations

View Task Force's Final Report HERE

The purpose of this final meeting was for the Task Force members to disseminate and discuss the final report in full detail. They debated and deliberated to carefully refine the language and terminology to avoid future misinterpretation or misapplication. They reviewed the consensus of thousands of comments submitted by the public during the previous public comment


Click Below for our Summary of the Meeting 


National News Coverage About Harmful effects on CPP'S

April 26th report by Shepard Smith about the harms to chronic pain patients as a result of the overarching CDC Guidelines. 

Link to Video:


Fox News' Greg Gutfeld has been reporting about our plight for several months.  Watch the most recent segment about the CDC Clarification featured on "The Five"

Watch segment here:  

Former Drug Czar Dr. William Bennett:  "the problem isn't rx to the coroner's, I have. It's Fentanyl & meth that's the major cause of death today."

 Jennifer Braceras, Esq. vs Dr. Mark Siegel discuss the Opioid Trial Verdict:

Did the government overcorrect on the opioid epidemic?

Jun. 26, 2019 - CDC guidelines have led to doctors cutting back on painkiller subscriptions, leaving patients fighting to get the medication they need.

Fox News’ Dagen Mcdowell's Mom suffering from bone CANCER has to fight with her doctor to receive pain medication.




HIPPA and the opioid crisis

The U.S. Department of Health and Human Services Office for Civil Rights has released new guidance explaining when HIPAA permits health care providers and other covered entities to share a patient’s health information with loved ones and others involved in a patient’s care in these situations.

The guidance explains:

  • Providers can share information with an individual patient's loved ones in certain emergency or dangerous situations, such as when the patient is in a crisis and incapacitated, or is facing a serious and imminent threat of harm.

  • Patients with decision-making capacity retain their right to decide when and whether their information will be shared, unless there is a serious and imminent threat of harm.

  • Patients' personal representatives, who have authority under state law to make health care decisions for patients, may request and obtain information on behalf of patients.

View the guidance.


Report Adverse Drug Effects to FDA

What to Report to MedWatch:

Use the MedWatch form to report adverse events that you observe or suspect for human medical products, including serious drug side effects, product use/medication error, product quality problems, and therapeutic failures for: 

  • Prescription or over-the-counter medicines, as well as medicines administered to hospital patients or at outpatient infusion centers
  • Biologics (including blood components, blood and plasma derivatives, allergenic, blood transfusions, gene therapies, and human cells and tissue transplants. For example, tendons, bone, and corneas)
  • Medical devices (including diabetes glucose-test kit, hearing aids, breast pumps, and many more products)
  • Combination products


Find a Pain Specialist

Find a Pain Specialist: 

Tips for Finding a Pain Specialist HERE:   

Tools for Patients: 

Search for pain management doctors from the following sources:

Find Upcoming Events in Your State: 



** URGENT BULLETIN ** Please SHARE with all State& Federal Representatives and Regulatory Agencies in charge of regulating Controlled Substances/Opioid prescribing. 

Re:  CDC Guideline Clarification Letter & FDA Advisory Notice pertaining to Opioid Prescribing 

Below is a letter from the CDC clarifying the 2016 Opioid Prescribing  Guideline and an Advisory Notice issued by the FDA regarding abrupt opioid tapering. 

Link to Clarification Letter from the CDC: CLICK  HERE

The Guideline is not intended to deny any patients who suffer with chronic pain from receiving opioid therapy as an option for pain management. Rather, the Guideline is intended to ensure that clinicians and patients consider all safe and effective treatment options for patients. 

Clinical decision-making should be based on the relationship between the clinician and patient, with an understanding of the patient’s clinical situation, functioning, and life context, as well as a careful consideration of the benefits and risk of all treatment options, including opioid therapy. 

CDC encourages physicians to continue to use their clinical judgment and base treatment on what they know about their patients, includes the use of opioids if determined to be the best course of treatment. Providers should communicate frequently with their patients to discuss both the benefits and risks of opioid therapy and revisit treatment plans for pain regularly to achieve the most positive outcomes for patients. 

Link to FDA Announcement CLICK HERE  

Reports of "serious harm" in patients dependent on opioid painkillerswho suddenly stop taking the medication, or rapidly decrease the dose, have prompted a drug safety communication issued today by the US Food and Drug Administration (FDA).







On April 10, the Director for the Centers for Disease Control and Prevention, Dr. Robert Redfield, wrote to Health Professionals for Patients in Pain (HP3) to state that the CDC’s 2016 Guideline offered no support for mandatory opioid dose reductions in patients with long-term pain. Coming on the heels of an April 9 warning from the United States Food and Drug Administration of “serious harm” to patients after rapid dose reduction or discontinuation, the Director’s letter flags the need for a recalibration of care decisions imposed by a wide range of private and governmental agencies that have invoked the CDC to justify coverage restrictions, quality metrics, legal threats and other actions to force dose reductions on nonconsenting patients.

Please CLICK BELOW to read Press Release & Access the CDC Director's Letter responding to the HP3 Letter 

Featured Websites & Groups


Want to Have Your Website or Group Featured Here to Drive New Members Your Way?  

Click BELOW for Instructions. 

Contact Us

Do You Have a Question or Want to Share Your Thoughts? Please Use this Form to Contact Our Team.

Stay in the Know

Sign up to Stay up to Date on the Latest News, Alerts, Deadlines, Calls to Action & Events Happening in the Pain Community.

Check out our Twitter Feed